SIREN : 531363083
SOBEMAB is a French company founded 15 years ago, specialized in the sector Activités de conditionnement. Based in CHANES (71570), this company of category PME shows in 2024 a revenue of 29.1 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 |
|---|---|---|
| Revenue | 29 067 596 € | 27 554 013 € |
| Net income | 1 004 302 € | 866 739 € |
| EBITDA | 2 381 549 € | 2 039 719 € |
| Net margin | 3.5% | 3.1% |
In 2024, SOBEMAB achieves revenue of 29.1 M€. Vs 2023: +5%. After deducting consumption (14.5 M€), gross margin stands at 14.6 M€, i.e. a rate of 50%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 2.4 M€, representing 8.2% of revenue. This level of operating margin is satisfactory for the sector. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 1.0 M€, i.e. 3.5% of revenue. This profit can be retained or distributed to shareholders.
29 067 596 €
14 599 114 €
2 381 549 €
1 550 168 €
1 004 302 €
8.2%
The debt ratio (= Financial debt / Equity x 100) stands at 41%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 50%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 1.7 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 6.7% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. Satisfactory level allowing partial financing of growth.
40.932%
49.665%
6.702%
1.717
29.5%
In 2024, the debt ratio of SOBEMAB (40.93) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2024, the financial autonomy of SOBEMAB (49.7%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
In 2024, the repayment capacity of SOBEMAB (1.72) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 225.80. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 1.6x. Coverage is limited: any activity downturn would jeopardize interest payments.
225.804
1.607
In 2024, the liquidity ratio of SOBEMAB (225.80) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
In 2024, the interest coverage of SOBEMAB (1.6x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 55 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 50 days. The company must finance 5 days of gap between collections and payments. Inventory turnover is 26 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. Overall, WCR represents 68 days of revenue, i.e. 5.5 M€ to permanently finance.
5 473 719 €
55 j
50 j
26 j
68 j
Based on 158 transactions of similar company sales (all years), the value of SOBEMAB is estimated at 7 736 368 € (range 3 085 468€ - 16 838 427€). With an EBITDA of 2 381 549€, the sector multiple of 3.3x is applied. The price/revenue ratio is 0.36x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 158 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare SOBEMAB with other companies in the same sector:
Voir toutes les statistiques du secteur Activités de conditionnement
The revenue of SOBEMAB in 2024 is 29.1 M€.
Yes, SOBEMAB generated a net profit of 1.0 M€ in 2024.
The headquarters of SOBEMAB is located in CHANES (71570), in the department Saone-et-Loire.
The tax return of SOBEMAB is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
SOBEMAB operates in the sector Activités de conditionnement (NAF code 82.92Z). See the 'Sector positioning' section above to compare the company with its competitors.